from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1132/-

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

2.003

Cap5-10ug/mL Capreomycintranslation

0.421

Rox10-50 ug/mL Roxithromycintranslation

-0.754

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.441

Rif0.2-5ug/mL Rifampicintranscription

0.211

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.691

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.283

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.039

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.517

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.094

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.806

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.952

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.184

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.291

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.536

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.237

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.556

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.069

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.131

KCN5-20 ug/mL Potassium cyaniderespiration

-0.078

NaN30.2-2 mM Sodium aziderespiration

-0.468

Nigericin50 uM Nigericinrespiration

-0.275

TRC10-150 ug/mL Triclosanrespiration

-0.647

TRZ10-25 ug/mL Thioridazinerespiration

-0.587

Valinomycin0.5-10 uM Valinomycinrespiration

0.939

ZnSO42 mM ZnSO4respiration

-0.284

menadione6-10 ug/mL Menadionerespiration

0.671

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.745

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.103

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.434

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.829

NRP_1Non-replicating persistence stage 1dosRassociated

1.588

Amp0.2mg/mL AmpicillincellWall

0.040

Cephalexin20-100 ug/mL CephalexincellWall

0.447

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.381

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.240

EMB10-20 ug/mL EthambutolcellWall

0.000

Eta12-40 ug/mL EthionamidecellWall

0.000

INH0.2-0.4 ug/mL IsoniazidcellWall

1.105

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.872

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.582

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.167

BZA0.12 mg/mL BenzamidearomaticAmides

0.158

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.150

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.252

H2O24 mM hydrogen peroxideDNAdamaging

0.594

Levo10 ug/mL LevofloxacinDNAdamaging

0.169

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.672

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.170

UVUV-irradiationDNAdamaging

-0.855

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.299

Antimycin12.5-50 ug/mL Antimycin A?

-0.303

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.341

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.129

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.770

PA8240.2-2 ug/mL PA-824?

2.537

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.211

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.394

Verapamil50 uM Verapamil?

0.071

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.358

methoxatin10-20 ug/mL Methoxatin?